Albion Venture Capital Trusts close £90M top-up offer as demand for UK innovation investments grows

The three Albion Venture Capital Trusts (VCTs) have today announced the completion of their £90 million top-up offer, which is now fully subscribed. 

The capital raised will be deployed into high-growth companies across Albion Capital’s core conviction sectors, including deeptech, healthcare, and B2B software. They provide investors with access to a diversified portfolio of innovative businesses, ranging from early-stage disruptors to established scale-ups.

The fundraise follows a period of strong portfolio momentum. Over the past five years, the Albion VCTs have raised over £405 million. Over the past three years, 64 per cent of portfolio companies have advanced from the growth stage to the scaleup stage.

Notable holdings include Quantexa, the global leader in decision intelligence solutions; Oviva, Europe’s leading digital health company for weight loss, which recently raised a £200 million Series D; and tem, the  AI-powered infrastructure that’s cutting energy costs for businesses.

Recent activity also includes significant growth rounds for deeptech and fintech innovators such as Gravity and TransFICC. 

Will Fraser-Allen, Managing Partner at Albion, commented:

"Reaching our £90 million hard cap, oversubscribed, reflects the growing recognition investors have that VCTs are one of the most effective ways to back the next generation of UK entrepreneurs, while targeting long-term, tax-efficient returns.

In an environment where tax efficiency and long-term growth are paramount, VCTs continue to offer a compelling proposition for those looking to back British breakthroughs.

With a strong pipeline of investment opportunities across our core sectors, we are well-positioned to deploy this capital into companies driving technological and scientific progress, supporting ambitious founders in sectors where the UK is a global leader, while creating value for our shareholders and the wider economy alike."